Literature DB >> 15261065

Interaction of cubosomes with plasma components resulting in the destabilization of cubosomes in plasma.

Warunee Leesajakul1, Minoru Nakano, Atsuhiko Taniguchi, Tetsurou Handa.   

Abstract

Cubosomes are novel dispersed nanoparticles with bicontinuous cubic phases of monoolein in their interior. We investigated their disintegration process in plasma by in vitro and in vivo studies. Cubosomes were incubated with whole plasma or plasma components such as HDL, LDL, and albumin. The lypolysis study indicated lipolytic activity of whole plasma towards cubosomes. Gel filtration chromatography revealed that HDL, LDL and albumin interacted with cubosomes. HDL affected cubosomes' integrity and gave rise to smaller particles which contained the components of both cubosomes and HDL. Upon incubation with LDL, cubosomes fused with LDL. Albumin was shown to take up monoolein out of the particles. Cubosomes were disintegrated by whole plasma as a result of the interaction with plasma components. It was concluded that in vivo observation of a long circulation time of a hydrophobic substance in cubosomes was due to the sustained behavior of cubosome remnant particles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15261065     DOI: 10.1016/j.colsurfb.2004.01.010

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  8 in total

1.  Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

Authors:  Di Bei; Jacob Marszalek; Bi-Botti C Youan
Journal:  AAPS PharmSciTech       Date:  2009-08-18       Impact factor: 3.246

2.  Nanostructured reverse hexagonal liquid crystals sustain plasma concentrations for a poorly water-soluble drug after oral administration.

Authors:  Tri-Hung Nguyen; Tracey Hanley; Christopher J H Porter; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2011-12       Impact factor: 4.617

Review 3.  Engineering nanomedicines for improved melanoma therapy: progress and promises.

Authors:  Di Bei; Jianing Meng; Bi-Botti C Youan
Journal:  Nanomedicine (Lond)       Date:  2010-11       Impact factor: 5.307

4.  Nanostructured Cubosomes in a Thermoresponsive Depot System: An Alternative Approach for the Controlled Delivery of Docetaxel.

Authors:  Nilesh R Rarokar; Suprit D Saoji; Nishikant A Raut; Jayashree B Taksande; Pramod B Khedekar; Vivek S Dave
Journal:  AAPS PharmSciTech       Date:  2015-07-25       Impact factor: 3.246

5.  Folic Acid-Targeted Etoposide Cubosomes for Theranostic Application of Cancer Cell Imaging and Therapy.

Authors:  Yong Tian; Jian-Chun Li; Jin-Xiu Zhu; Na Zhu; Hong-Min Zhang; Lili Liang; Lingyi Sun
Journal:  Med Sci Monit       Date:  2017-05-22

6.  Stimuli-Responsive Lyotropic Liquid Crystalline Nanosystems with Incorporated Poly(2-Dimethylamino Ethyl Methacrylate)-b-Poly(Lauryl Methacrylate) Amphiphilic Block Copolymer.

Authors:  Maria Chountoulesi; Natassa Pippa; Varvara Chrysostomou; Stergios Pispas; Evangelia D Chrysina; Aleksander Forys; Lukasz Otulakowski; Barbara Trzebicka; Costas Demetzos
Journal:  Polymers (Basel)       Date:  2019-08-26       Impact factor: 4.329

7.  A novel multi-functionalized multicellular nanodelivery system for non-small cell lung cancer photochemotherapy.

Authors:  Yongtai Zhang; Qing Xia; Tong Wu; Zehui He; Yanyan Li; Zhe Li; Xuefeng Hou; Yuanzhi He; Shuyao Ruan; Zhi Wang; Jia Sun; Nianping Feng
Journal:  J Nanobiotechnology       Date:  2021-08-14       Impact factor: 10.435

8.  From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF).

Authors:  Claire Géral; Angelina Angelova; Sylviane Lesieur
Journal:  Pharmaceutics       Date:  2013-02-08       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.